2024-11-19 17:25:06
Qiming's Portfolio Company InventisBio Lists on STAR Market
Corporate/ 2023-07-24
Qiming's Portfolio Company Inventis...

SHANGHAI,July 25,2022-- Qiming Venture Partners\' portfolio company InventisBio (SHSE: 688382),a leading company in innovative drug developm...

Anti-PD-1 monoclonal antibody Puyouheng™ (HX-008, Pucotenlimab injection) Co-developed by LEPU BIOPHARMA and HANX BIOPHARMACEUTICALS was approved for marketing in China by NMPA
Health/ 2023-07-22
Anti-PD-1 monoclonal antibody Puyouheng™...

HANGZHOU,China,July 25,2022-- Anti-PD-1 monoclonal antibody – PuyouhengTM (HX-008,pucotenlimab injection),was conditionally approved by the...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release